Kimberly Kraig Thompson Kraig Biocraft Laboratories, Inc (KBLB) insider trading activity

KBLB Quotes by TradingView

Kimberly Kraig Thompson is CEO & CFO of Kraig Biocraft Laboratories, Inc. Currently has a direct ownership of 202 Million shares of KBLB, which is worth approximately $16.1 Million. The most recent transaction as insider was on Jul 21, 2021, when has been sold 10,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 202M
0% 3M change
0% 12M change
Total Value Held $16.1 Million

Kimberly Kraig Thompson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 21 2021
SELL
Open market or private sale
-
10,000 Reduced 0.0%
203,660,547 Common Stock
Jul 19 2021
SELL
Open market or private sale
-
20,000 Reduced 0.01%
203,670,547 Common Stock
Jul 15 2021
SELL
Open market or private sale
-
22,900 Reduced 0.01%
203,690,547 Common Stock
Jul 13 2021
SELL
Open market or private sale
-
10,000 Reduced 0.0%
203,713,447 Common Stock
Jul 12 2021
SELL
Open market or private sale
-
26,100 Reduced 0.01%
203,723,447 Common Stock
Jul 09 2021
SELL
Open market or private sale
-
120,000 Reduced 0.06%
203,749,547 Common Stock
Jul 07 2021
SELL
Open market or private sale
-
60,000 Reduced 0.03%
203,809,547 Common Stock
Jul 02 2021
SELL
Open market or private sale
-
60,000 Reduced 0.03%
203,869,547 Common Stock
Jun 29 2021
SELL
Open market or private sale
-
40,000 Reduced 0.02%
203,929,547 Common Stock
Jun 28 2021
SELL
Open market or private sale
-
28,572 Reduced 0.01%
203,969,547 Common Stock
Jun 25 2021
SELL
Open market or private sale
-
50,000 Reduced 0.02%
203,998,299 Common Stock
Jun 24 2021
SELL
Open market or private sale
-
30,000 Reduced 0.01%
204,048,299 Common Stock
Jun 18 2021
SELL
Open market or private sale
-
30,000 Reduced 0.01%
204,078,299 Common Stock
Jun 10 2021
SELL
Open market or private sale
-
50,000 Reduced 0.02%
204,108,299 Common Stock
Jun 09 2021
SELL
Open market or private sale
-
19,000 Reduced 0.01%
204,158,299 Common Stock
Jun 08 2021
SELL
Open market or private sale
-
50,000 Reduced 0.02%
204,177,299 Common Stock
Jun 07 2021
SELL
Open market or private sale
-
30,000 Reduced 0.01%
204,227,299 Common Stock
Jun 03 2021
SELL
Open market or private sale
-
35,585 Reduced 0.02%
204,257,299 Common Stock
Jun 01 2021
SELL
Open market or private sale
-
60,000 Reduced 0.03%
204,292,884 Common Stock
May 25 2021
SELL
Open market or private sale
-
10,000 Reduced 0.0%
204,352,884 Common Stock
May 24 2021
SELL
Open market or private sale
-
15,000 Reduced 0.01%
204,362,884 Common Stock
May 19 2021
SELL
Open market or private sale
-
26,510 Reduced 0.01%
204,377,884 Common Stock
May 18 2021
SELL
Open market or private sale
-
70,000 Reduced 0.03%
204,404,394 Common Stock
May 17 2021
SELL
Open market or private sale
-
20,600 Reduced 0.01%
204,474,394 Common Stock
May 13 2021
SELL
Open market or private sale
-
15,000 Reduced 0.01%
204,494,994 Common Stock
KKT

Kimberly Kraig Thompson

CEO & CFO
Ann Arbor,, MI

Track Institutional and Insider Activities on KBLB

Follow Kraig Biocraft Laboratories, Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KBLB shares.

Notify only if

Insider Trading

Get notified when an Kraig Biocraft Laboratories, Inc insider buys or sells KBLB shares.

Notify only if

News

Receive news related to Kraig Biocraft Laboratories, Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KBLB